The outcome of COVID‐19 in patients with hematological malignancyTuğçe Nur Yiğenoğlu, Şuayıp Birinci, Naim Ata et al.|Journal of Medical Virology|2020Cited by 134
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitorsSemih Başçı, Fevzi Altuntaş, Sinem Namdaroğlu et al.|Journal of Oncology Pharmacy Practice|2020Cited by 40
Older Adults With Coronavirus Disease 2019: A Nationwide Study in TurkeyMert Eşme, Şuayıp Birinci, Burcu Balam Doğu et al.|The Journals of Gerontology Series A|2020Cited by 34
COVID-19 in hematopoietic cell transplant recipientsŞuayıp Birinci, Fevzi Altuntaş, Sinem Namdaroğlu et al.|Bone Marrow Transplantation|2020Cited by 31
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancersSemih Başçı, Fevzi Altuntaş, Sinem Namdaroğlu et al.|Internal and Emergency Medicine|2021Cited by 19